Corrêa FA, de
Arruda JAA, Drumond VZ, Cepeda IVB, Tarquinio SBC, Silva TA, Abreu LG, Rivero
ERC, Mesquita RA, Etges A. Pharmacological therapy for central giant cell
granuloma of the jaws: A systematic review. J Clin Exp Dent.
2024;16(7):e885-97.
doi:10.4317/jced.61490
https://doi.org/10.4317/jced.61490
_____
References
1.
Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions
of the jaws: a clinicopathologic study. J Oral Maxillofac Surg.
1986;44:708-13. |
|
|
|
2.
Nosé V, Lazar AJ. Update from the 5th edition of the World Health
Organization classification of head and neck tumors: familial tumor
syndromes. Head Neck Pathol. 2022;16:143-57. |
|
|
|
3.
Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous
(fibro-oseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol.
1953;6:159-75. |
|
|
|
4.
Alsufyani NA, Aldosary RM, Alrasheed RS, Alsaif RF. A systematic review of
the clinical and radiographic features of hybrid central giant cell granuloma
lesions of the jaws. Acta Odontol Scand. 2021;79:124-31. |
|
|
|
5.
Schreuder WH, van den Berg H, Westermann AM, Peacock ZS, de Lange J.
Pharmacological and surgical therapy for the central giant cell granuloma: A
long-term retrospective cohort study. J Craniomaxillofac Surg.
2017;45:232-43. |
|
|
|
6.
Miguita L, de Souza JC, Bastos VC, Pereira NB, de Freitas RAB, Guimarães LM,
et al. Central giant cell granulomas of the jaws stromal cells harbour
mutations and have osteogenic differentiation capacity, in vivo and in vitro.
J Oral Pathol Med. 2022;51:206-16. |
|
|
|
7.
Chrcanovic BR, Gomes CC, Gomez RS. Central giant cell lesion of the jaws: an
updated analysis of 2270 cases reported in the literature. J Oral Pathol Med.
2018;47:731-9. |
|
|
|
8.
Abdo EN, Alves LC, Rodrigues AS, Mesquita RA, Gomez RS. Treatment of a
central giant cell granuloma with intralesional corticosteroid. Br J Oral
Maxillofac Surg. 2005;43:74-6. |
|
|
|
9.
Chrcanovic BR, Gomes CC, Dos Santos TR, Abreu MHNG, Gomez RS. Clinical
factors associated with the recurrence of central giant cell lesions. J Oral
Pathol Med. 2019;48:799-802. |
|
|
|
10.
Camarini C, de Souza Tolentino E. Non-surgical treatment as an alternative
for the management of central giant cell granuloma: a systematic review. Clin
Oral Investig. 2022;26:2111-32. |
|
|
|
11.
de Lange J, van den Akker HP, van den Berg H. Central giant cell granuloma of
the jaw: a review of the literature with emphasis on therapy options. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:603-15. |
|
|
|
12.
Suárez-Roa Mde L, Reveiz L, Ruíz-Godoy Rivera LM, Asbun-Bojalil J,
Dávila-Serapio JE, Menjívar-Rubio AH, et al. Interventions for central giant
cell granuloma (CGCG) of the jaws. Cochrane Database Syst Rev. 2009;CD007404. |
|
|
|
13.
Nissen T, Wynn R. The clinical case report: a review of its merits and
limitations. BMC Res Notes. 2014;7:264. |
|
|
|
14.
Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB. Antiangiogenic
therapy with interferon alpha for giant cell lesions of the jaws. J Oral
Maxillofac Surg. 2002;60:1103-11; discussion 1111-13. |
|
|
|
15.
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group*. The
CARE guidelines: consensus-based clinical case reporting guideline
development. Glob Adv Health Med. 2013;2:38-43. |
|
|
|
16.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.
The PRISMA 2020 statement: An updated guideline for reporting systematic
reviews. Int J Surg. 2021;88:105906. |
|
|
|
17.
Adornato MC, Paticoff KA. Intralesional corticosteroid injection for treatment
of central giant-cell granuloma. J Am Dent Assoc. 2001;132:186-90. |
|
|
|
18.
Al-Ahmad HT, Anabtawi M, Salfiti F, Eid RA. Combination of surgery followed
by intralesional steroids in treatment of aggressive mandibular giant cell
granuloma: a case report. Jordan Med J. 2009;43:231-7. |
|
|
|
19.
Al-Jandan B. Combined management of large aggressive central giant cell granuloma
of the mandible: a case report. Saudi J Dent Res. 2015;6:157-60. |
|
|
|
20.
Al-Layla AM, Mahazfa T. Giant cell granuloma of the maxillary sinus; a case
report. Jordan Med J. 2013;47:260-5. |
|
|
|
21.
Aoki T, Karakida K, Sakamoto H, Yamazaki H, Otsuru M, Sasaki M, et al.
Successful treatment by intralesional steroid injection in management of
central giant cell granuloma of the jaw-report of two cases. J Oral
Maxillofac Surg Med Pathol. 2012;24:213-7. |
|
|
|
22.
Aurora JK, Chauhan H, Loomba K, Potlia I. Novel regimen of combined
intralesional triamcinolone and salmon calcitonin nasal spray to treat a
large central giant cell granuloma. Natl J Maxillofac Surg. 2022;13:S131-5. |
|
|
|
23.
Baker SB, Parikh PM, Rhodes DN, Abu-Ghosh A, Shad AT. Aggressive central
giant cell lesion of the maxilla: surgical management and the use of adjuvant
interferon alfa-2a. Plast Reconstr Surg. 2008;122:77-9. |
|
|
|
24.
Bayar OF, Ak G. Treatment of giant cell granuloma with intralesional
corticosteroid injections: a case report. J Istanb Univ Fac Dent.
2015;49:45-50. |
|
|
|
25.
Cavalcante IL, Barros CCS, Osterne RLV, Cavalcante RB, Nogueira RLM, Medeiros
RCT. Conservative therapy for central giant cell lesion: case report J Bras
Patol Med Lab. 2017;53:403-6. |
|
|
|
26.
Chien MC, Mascarenhas L, Hammoudeh JA, Venkatramani R. Zoledronic acid for
the treatment of children with refractory central giant cell granuloma. J
Pediatr Hematol Oncol. 2015;37:e399-401. |
|
|
|
27.
Choi JW, Kraut RA. Management of central giant granuloma of mandible with
intralesional triamcinolone injections: a case report. N Y State Dent J.
2013;79:34-6. |
|
|
|
28.
Comert E, Turanli M, Ulu S. Oral and intralesional steroid therapy in giant
cell granuloma. Acta Otolaryngol. 2006;126:664-6. |
|
|
|
29.
da Rosa MRP, de Sá JL, Martins VB, de Oliveira MV. Central giant cells
lesion: report of a conservative management. Eur J Dent. 2018;12:305-10. |
|
|
|
30.
da Silva NG, Carreira AS, Pedreira EN, Tuji FM, Ortega KL, de Jesus Viana
Pinheiro J. Treatment of central giant cell lesions using bisphosphonates
with intralesional corticosteroid injections. Head Face Med. 2012;8:23. |
|
|
|
31.
da Silva Sampieri MB, Yaedú RY, Santos PS, Gonçales ES, Santa'ana E,
Consolaro A, et al. Central giant cell granuloma: treatment with calcitonin,
triamcinolone acetonide, and a cystic finding 3 years and 6 months after the
primary treatment. Oral Maxillofac Surg. 2013;17:229-34. |
|
|
|
32.
de Arruda JAA, Martins AFL, Abreu LG, Mesquita RA, von Zeidler SV, Estrela C,
et al. Central giant cell granuloma of the maxilla: long-term follow-up of a
patient treated with an adjuvant corticosteroid. Spec Care Dentist.
2021;41:399-407. |
|
|
|
33.
de Lange J, van den Akker HP, van den Berg H, Richel DJ, Gortzak RA. Limited
regression of central giant cell granuloma by interferon alpha after failed
calcitonin therapy: a report of 2 cases. Int J Oral Maxillofac Surg.
2006;35:865-9. |
|
|
|
34.
de Mendonça RP, Mitre GP, Real FH, da Silva Kataoka MS, de Melo Alves Júnior
S, Vianna P, et al. Central giant cell granuloma treated with intralesional
corticosteroid injections and bisphosphonates: a long-term follow-up case
study. Head Neck Pathol. 2020;14:497-502. |
|
|
|
35.
de Oliveira JP, Olivete F, de Oliveira ND, Giovanini AF, Zielak JC, Klüppel
L, et al. Combination therapies for the treatment of recurrent central giant
cell lesion in the maxilla: a case report. J Med Case Rep. 2017;11:74. |
|
|
|
36.
de Oliveira LJ, Lehman LFC, Gomez RS, Castro WH. Treatment of central giant
cell lesions. Oral Surg. 2016;9:52-7. |
|
|
|
37.
El Hadidi YN, Ghanem AA, Helmy I. Injection of steroids intralesional in
central giant cell granuloma cases (giant cell tumor): is it free of systemic
complications or not? A case report. Int J Surg Case Rep. 2015;8C:166-70. |
|
|
|
38.
Fernandes Gonçalves IM, Barbosa Luna AH, de Melo DP, Weege Nonaka CF, Alves
PM. Pharmacological therapy for treatment of recurrent central giant cell
lesion in a child. J Dent Child (Chic). 2019;86:113-7. |
|
|
|
39.
Ferretti C, Muthray E. Management of central giant cell granuloma of mandible
using intralesional corticosteroids: case report and review of literature. J
Oral Maxillofac Surg. 2011;69:2824-9. |
|
|
|
40.
Fonseca FP, Ribeiro AC, Santos-Silva AR, Vargas PA, Lopes MA. Fine needle
aspiration cytology and intralesional steroid injection in a central giant
cell granuloma affecting the gingiva: a new clinical approach. Braz Dent J.
2013;24:420-7. |
|
|
|
41.
Goldman KE, Marshall MK, Alessandrini E, Bernstein ML. Complications of
alpha-interferon therapy for aggressive central giant cell lesion of the
maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:285-91. |
|
|
|
42.
Goyal P, Narula R, Bansal S, Bansal S, Garg P. Conservative nonsurgical
treatment of mandibular central giant cell granuloma in an adolescent: a case
report. Pediatr Dent J. 2014;24:58-62. |
|
|
|
43.
Gupta B, Stanton N, Coleman H, White C, Singh J. A novel approach to the
management of a central giant cell granuloma with denosumab: a case report
and review of current treatments. J Craniomaxillofac Surg. 2015;43:1127-32. |
|
|
|
44.
Jerkins D, Malotky M, Miremadi R, Dole M. Central giant cell granuloma of the
mandible requiring multiple treatment modalities: a case report. J Oral
Maxillofac Surg. 2016;74:1596-607. |
|
|
|
45.
Joshi S, Koranne V, Pawar S, Pawar P, Lakhani K,Salema H. Conservative
management of central giant cell granuloma - A case report. J Indian Acad
Oral Med Radiol 2023;35:141-3. |
|
|
|
46.
Khafif A, Krempl G, Medina JE. Treatment of giant cell granuloma of the
maxilla with intralesional injection of steroids. Head Neck. 2000;22:822-5. |
|
|
|
47.
Kurtz M, Mesa M, Alberto P. Treatment of a central giant cell lesion of the
mandible with intralesional glucocorticosteroids. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2001;91:636-7. |
|
|
|
48.
Lietman SA, Levine MA. Resolution of giant cell granuloma after treatment
with calcitonin. Oral Oncology Extra. 2005;41:125-7. |
|
|
|
49.
Mariz BALA, Migliorati CA, Alves FA, Penteado FM, Carvalho NP Filho,
Santos-Silva AR, et al. Successful denosumab treatment for central giant cell
granuloma in a 9-year-old child. Spec Care Dentist. 2021;41:519-25. |
|
|
|
50.
Matos FR, Sarmento DJS, Neto AC, Miguel MCC, da Silveira ÉJD. Central giant
cell lesion in pediatric patient: case report and literature review of 33
cases. Int J Clin Dent. 2016;6:33-42. |
|
|
|
51.
Mohanty S, Jhamb A. Central giant cell lesion of mandible managed by
intralesional triamcinolone injections. A report of two cases and literature
review. Med Oral Patol Oral Cir Bucal. 2009;14:E98-102. |
|
|
|
52.
Moura LB, Tarquinio SBC, Gomes APN, Schinestsck AR, Torriani MA. Modified
approach to central giant cell lesion. J Clin Pediatr Dent. 2018;42:292-4. |
|
|
|
53.
Mukdad M, Barut O, Sjöström M. Intralesional corticosteroid injections as
first option for management of giant cell lesion of the lower jaw in a
56-year-old patient: a case report and brief literature review. Oral
Maxillofac Surg Cases. 2022;8:100283. |
|
|
|
54.
Naidu A, Malmquist MP, Denham CA, Schow SR. Management of central giant cell
granuloma with subcutaneous denosumab therapy. J Oral Maxillofac Surg.
2014;72:2469-84. |
|
|
|
55.
Nilesh K, Dadhich A, Patil R. Management of recurrent central giant cell
granuloma of mandible using intralesional corticosteroid with long-term
follow-up. BMJ Case Rep. 2020;13:e237200. |
|
|
|
56.
Nogueira RL, Teixeira RC, Cavalcante RB, Ribeiro RA, Rabenhosrt SH.
Intralesional injection of triamcinolone hexacetonide as an alternative
treatment for central giant-cell granuloma in 21 cases. Int J Oral Maxillofac
Surg. 2010;39:1204-10. |
|
|
|
57.
O'Connell JE, Bowe C, Murphy C, Toner M, Kearns GJ. Aggressive giant cell
lesion of the jaws: a review of management options and report of a mandibular
lesion treated with denosumab. Oral Surg Oral Med Oral Pathol Oral Radiol.
2015;120:e191-8. |
|
|
|
58.
O'Connell JE, Kearns GJ. Aggressive giant cell granuloma of the jaws treated
with interferon alpha: a report of two cases. Ir J Med Sci. 2013;182:163-70. |
|
|
|
59.
O'Regan EM, Gibb DH, Odell EW. Rapid growth of giant cell granuloma in
pregnancy treated with calcitonin. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 2001;92:532-8. |
|
|
|
60.
Pogrel MA, Regezi JA, Harris ST, Goldring SR. Calcitonin treatment for
central giant cell granulomas of the mandible: report of two cases. J Oral
Maxillofac Surg. 1999;57:848-53. |
|
|
|
61.
Rachmiel A, Emodi O, Sabo E, Aizenbud D, Peled M. Combined treatment of
aggressive central giant cell granuloma in the lower jaw. J Craniomaxillofac
Surg. 2012;40:292-7. |
|
|
|
62.
Rajeevan NS, Soumithran CS. Intralesional corticosteroid injection for
central giant cell granuloma. A case report. Int J Oral Maxillofac Surg.
1998;27:303-4. |
|
|
|
63.
Romero M, Romance A, Garcia-Recuero JI, Fernández Á. Orthopedic and
orthodontic treatment in central giant cell granuloma treated with
calcitonin. Cleft Palate Craniofac J. 2011;48:519-25. |
|
|
|
64.
Schreuder WH, Coumou AW, Kessler PA, de Lange J. Alternative pharmacologic
therapy for aggressive central giant cell granuloma: denosumab. J Oral
Maxillofac Surg. 2014;72:1301-9. |
|
|
|
65.
Schütz P, El-Bassuoni KH, Munish J, Hamed HH, Padwa BL. Aggressive central
giant cell granuloma of the mandible. J Oral Maxillofac Surg.
2010;68:2537-44. |
|
|
|
66.
Sezer B, Koyuncu B, Gomel M, Günbay T. Intralesional corticosteroid injection
for central giant cell granuloma: a case report and review of the literature.
Turk J Pediatr. 2005;47:75-81. |
|
|
|
67.
Shirani G, Abbasi AJ, Mohebbi SZ, Shirinbak I. Management of a locally
invasive central giant cell granuloma (CGCG) of mandible: report of an
extraordinary large case. J Craniomaxillofac Surg. 2011;39:530-3. |
|
|
|
68.
Stagner AM, Sajed DP, Nielsen GP, Ebb DH, Faquin WC, Chebib I, et al. Giant
cell lesions of the maxillofacial skeleton express RANKL by RNA in situ
hybridization regardless of histologic pattern. Am J Surg Pathol. 2019;43:819-26. |
|
|
|
69.
Tallent B, Padilla RJ, McKay C, Foreman AKM, Fan Z, Blatt J. Response of
central giant cell granuloma of the jaw to imatinib. J Pediatr Hematol Oncol.
2023;45:278-80. |
|
|
|
70.
Tarsitano A, Del Corso G, Pizzigallo A, Marchetti C. Aggressive central giant
cell granuloma of the mandible treated with conservative surgical enucleation
and interferon-α-2a: complete remission with long-term follow-up. J Oral
Maxillofac Surg. 2015;73:2149-54. |
|
|
|
71.
Toferer A, Truschnegg A, Merl L, Liegl-Atzwanger B, Zemann W, Beham A.
Dilemma in the treatment of a central giant cell granuloma. J Clin Pediatr
Dent. 2021;45:337-40. |
|
|
|
72.
Wendt FP, Torriani MA, Gomes AP, de Araujo LM, Torriani DD. Intralesional
corticosteroid injection for central giant cell granuloma: an alternative
treatment for children. J Dent Child (Chic). 2009;76:229-32. |
|
|
|
73.
Yazici N, Yalçin B, Yilmaz T, Akyüz C, Oguz KK, Arzu Sungur, et al. Surgery
and calcitonin therapy in childhood central giant cell granuloma. Int J Pediatr
Otorhinolaryngol. 2006;1:297-300. |
|
|
|
74.
Allon DM, Anavi Y, Calderon S. Central giant cell lesion of the jaw:
nonsurgical treatment with calcitonin nasal spray. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2009;107:811-8. |
|
|
|
75.
Borges HO, Machado RA, Vidor MM, Beltrão RG, Heitz C, Filho MS. Calcitonin: a
non-invasive giant cells therapy. Int J Pediatr Otorhinolaryngol.
2008;72:959-63. |
|
|
|
76.
Bredell M, Rordorf T, Kroiss S, Rücker M, Zweifel DF, Rostetter C. Denosumab
as a treatment alternative for central giant cell granuloma: a long-term
retrospective cohort study. J Oral Maxillofac Surg. 2018;76:775-84. |
|
|
|
77.
Carlos R, Sedano HO. Intralesional corticosteroids as an alternative
treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 2002;93:161-6. |
|
|
|
78.
Chandna P, Srivastava N, Bansal V, Wadhwan V, Dubey P. Peripheral and central
giant cell lesions in children: institutional experience at Subharti dental
college and hospital. Indian J Med Paediatr Oncol. 2017;38:440-6. |
|
|
|
79.
Choe M, Smith V, Okcu MF, Wulff J, Gruner S, Huisman TAGM, Venkatramani R.
Treatment of central giant cell granuloma in children with denosumab. Pediatr
Blood Cancer. 2021;68:e28778. |
|
|
|
80.
de Lange J, Rosenberg AJ, van den Akker HP, Koole R, Wirds JJ, van den Berg
H. Treatment of central giant cell granuloma of the jaw with calcitonin. Int
J Oral Maxillofac Surg. 1999;28:372-6. |
|
|
|
81.
Dolanmaz D, Esen A, Mihmanlı A, Işık K. Management of central giant cell
granuloma of the jaws with intralesional steroid injection and review of the
literature. Oral Maxillofac Surg. 2016;20:203-9. |
|
|
|
82.
Harris M. Central giant cell granulomas of the jaws regress with calcitonin
therapy. Br J Oral Maxillofac Surg. 1993;31:89-94. |
|
|
|
83.
Kim TS, Usera GL, Ruggiero SL, Weinerman SA. Improvement of giant cell
lesions of the jaw treated with high and low doses of denosumab: a case
series. JBMR Plus. 2017;1:101-6. |
|
|
|
84.
Maia Nogueira RL, Osterne RL, Cavalcante RB, Abreu RT. Surgical treatment,
oral rehabilitation, and orthognathic surgery after failure of pharmacologic
treatment of central giant cell lesion: a case report. J Oral Maxillofac
Surg. 2016;74:2567.e1-2567.e10. |
|
|
|
85.
Niedzielska I, Bielecki M, Bąk M, Dziuk B, Niedzielski D. Bony canal method
of dexamethasone injections in aggressive form of central giant cell
granuloma-case series. Medicina (Kaunas). 2023;59:250. |
|
|
|
86.
Nogueira RLM, Osterne RLV, Lima Verde RMB, Azevedo NO, Teixeira RC,
Cavalcante RB. Intralesional injection of triamcinolone hexacetonide as an
alternative treatment for central giant cell lesions: a prospective study. Br
J Oral Maxillofac Surg. 2020;58:e283-9. |
|
|
|
87.
Pogrel MA. Calcitonin therapy for central giant cell granuloma. J Oral
Maxillofac Surg. 2003;61:649-53; discussion 53-4. |
|
|
|
88.
Rhou YJJ, Wang CJ, Nguyen M, Vanderniet JA, Munns CF, Coleman H, Kim J,
Holmes-Walker DJ, Lim L, Girgis CM. Clinical and radiologic response of
central giant cell granuloma to denosumab: a 6-year prospective observational
study. Calcif Tissue Int. 2022;110:464-74. |
|
|
|
89.
Schreuder WH, Peacock ZS, Ebb D, Chuang SK, Kaban LB. Adjuvant antiangiogenic
treatment for aggressive giant cell lesions of the jaw: a 20-year experience
at Massachusetts general hospital. J Oral Maxillofac Surg. 2017;75:105-18. |
|
|
|
90.
Vanderniet JA, Wall CL, Mullins A, London K, Lim L, Hibbert S, et al.
Denosumab for central giant cell granuloma in an Australian tertiary
paediatric centre. Bone. 2022;159:116395. |
|
|
|
91.
Elias LS, Costa RF, Carvalho MA, Batista AC, Silva TA, Leles CR, et al.
Markers of bone remodeling in neoplastic and bone-related lesions. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 2010;110:624-31. |
|
|
|
92.
Osterne RL, Araújo PM, de Souza-Carvalho AC, Cavalcante RB, Sant'Ana E,
Nongueira RL. Intralesional corticosteroid injections in the treatment of
central giant cell lesions of the jaws: a meta-analytic study. Med Oral Patol
Oral Cir Bucal. 2013;18:e226-32. |
|
|
|
93.
Batista Severo ML, Lopes MLDS, Miguel MCDC, Germano AR, Nogueira RLM, Turatti
E, et al. Immunoexpression of calcitonin and glucocorticoid receptors in
central giant cell lesions of the jaws. J Oral Pathol Med. 2018;47:907-13. |
|
|
|
94.
Xie J, Guo J, Kanwal Z, Wu M, Lv X, Ibrahim NA, et al. Calcitonin and bone
physiology: in vitro, in vivo, and clinical investigations. Int J Endocrinol.
2020;2020:3236828. |
|
|
|
95.
Tabrizi R, Fardisi S, Zamiri B, Amanpour S, Karagah T. Can calcitonin nasal
spray reduce the risk of recurrence of central giant cell granuloma of the
jaws? A double-blind clinical trial. Int J Oral Maxillofac Surg.
2016;45:756-9. |
|
|
|
96.
Polyzos SA, Makras P, Tournis S, Anastasilakis AD. Off-label uses of
denosumab in metabolic bone diseases. Bone. 2019;129:115048. |